The use of antiplatelets is widespread in clinical practice. However, for neurointerventional
procedures, protocols for antiplatelet use are scarce and practice varies between individuals …

Background: Intra-and postprocedural thrombosis are major complication of aneurysmal coil
embolization, stent-assisted coiling, and pipeline embolization. The common but unproven …

Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

BACKGROUND The use of antiplatelet medications to prevent thrombosis in the treatment of
cerebral aneurysms with stents has become widely emphasized. OBJECTIVE To compare …

Background Thromboembolic complications are the main problem in stent-assisted coil
embolization of unruptured intracranial aneurysms. The combination of aspirin and …

BACKGROUND Antiplatelet premedication is widely accepted for interventional treatment of
cerebral aneurysms to prevent thromboembolism. However, antiplatelet resistance …

BACKGROUND: Clopidogrel is routinely used to decrease ischemic complications during
neurointerventional procedures. However, the efficacy may be limited by antiplatelet …

Background Dual antiplatelet therapy is widely used for stent-assisted coil embolization
(SACE) for unruptured intracranial aneurysms (UIAs) to prevent thromboembolic events …

Background and purpose Prophylactic prasugrel for endovascular treatment of intracranial
aneurysms has been introduced and increased, but HTPR (high on-treatment platelet …

Purpose Antiplatelet maintenance after stent-assisted coil embolization (SACE) is generally
considered essential to avoid post-procedural thromboembolic complications. However …